Recent Finacing
Recent Raise
InVasc Therapeutics is a biopharmaceutical company developing small-molecule and biologic therapies for cardiometabolic diseases, advancing INV-144 to reduce proteinuria and slow chronic kidney disease in hypertensive diabetics.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
